{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:04:49Z","timestamp":1791223489118,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52472288"],"award-info":[{"award-number":["52472288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52203362"],"award-info":[{"award-number":["52203362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52072253"],"award-info":[{"award-number":["52072253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20254"],"award-info":[{"award-number":["U20A20254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFB3804600"],"award-info":[{"award-number":["2022YFB3804600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018541","name":"Science Fund for Distinguished Young Scholars of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20211544"],"award-info":[{"award-number":["BK20211544"]}],"id":[{"id":"10.13039\/501100018541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biomaterials.2024.123063","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:56:38Z","timestamp":1735239398000},"page":"123063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Bioactive microspheres to enhance sonodynamic-embolization-metalloimmune therapy for orthotopic liver cancer"],"prefix":"10.1016","volume":"317","author":[{"given":"Jiachen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6166-9678","authenticated-orcid":false,"given":"Zifan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-9094","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biomaterials.2024.123063_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.123063_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.123063_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12029-017-9959-0","article-title":"Global epidemiology of hepatocellular carcinoma (HCC epidemiology)","volume":"48","author":"Ozakyol","year":"2017","journal-title":"J. Gastrointest. Cancer"},{"issue":"3\u20134","key":"10.1016\/j.biomaterials.2024.123063_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000343828","article-title":"Treatment of hepatocellular carcinoma: a systematic review","volume":"1","author":"Lin","year":"2012","journal-title":"Liver Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.123063_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-022-01235-0","article-title":"Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)","volume":"8","author":"Zhu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000449347","article-title":"Transarterial therapies for hepatocellular carcinoma","volume":"6","author":"Lanza","year":"2016","journal-title":"Liver Cancer"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.123063_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1148\/radiol.11081489","article-title":"Transcatheter intraarterial therapies: rationale and overview","volume":"259","author":"Lewandowski","year":"2011","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.123063_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0034-1394142","article-title":"Transarterial chemoembolization and radioembolization","volume":"34","author":"Sangro","year":"2014","journal-title":"Semin. Liver Dis."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.123063_bib10","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.jvir.2008.06.017","article-title":"Comparison of hypoxia-inducible factor-1\u03b1 expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors","volume":"19","author":"Virmani","year":"2008","journal-title":"J. Vasc. Intervent. Radiol."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.123063_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/1078-0432.CCR-19-1702","article-title":"Molecular imaging of extracellular tumor pH to reveal effects of locoregional therapy on liver cancer microenvironment","volume":"26","author":"Savic","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib12","article-title":"The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma","author":"Liu","year":"2022","journal-title":"Cochrane DB. Syst. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2010.10.005","article-title":"Trans-arterial chemoembolization as a therapy for liver tumours: new clinical developments and suggestions for combination with angiogenesis inhibitors","volume":"80","author":"Gadaleta","year":"2011","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000486487","article-title":"Combination cancer immunotherapy in hepatocellular carcinoma","volume":"7","author":"Kudo","year":"2018","journal-title":"Liver Cancer"},{"issue":"23","key":"10.1016\/j.biomaterials.2024.123063_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201900730","article-title":"Ultrasmall oxygen-deficient bimetallic oxide MnWOX nanoparticles for depletion of endogenous GSH and enhanced sonodynamic cancer therapy","volume":"31","author":"Gong","year":"2019","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.biomaterials.2024.123063_bib16","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1039\/D1CS00403D","article-title":"Advanced biotechnology-assisted precise sonodynamic therapy","volume":"50","author":"Zhang","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"47","key":"10.1016\/j.biomaterials.2024.123063_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003214","article-title":"Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy","volume":"32","author":"Liang","year":"2020","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.123063_bib18","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1039\/C9CS00648F","article-title":"Multifunctional sonosensitizers in sonodynamic cancer therapy","volume":"49","author":"Son","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.123063_bib19","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.chempr.2020.02.020","article-title":"Synthesis of CaCO3-based nanomedicine for enhanced sonodynamic therapy via amplification of tumor oxidative stress","volume":"6","author":"Dong","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.biomaterials.2024.123063_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101585","article-title":"Manganese-doping titanium disulfide cascade nanobioreactors for sequential gas-sonodynamic strategy with immune checkpoint blockade therapy of cancer","volume":"46","author":"Yang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2024.123063_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101212","article-title":"Targeting ferroptosis synergistically sensitizes apoptotic sonodynamic anti-tumor nanotherapy","volume":"39","author":"Zhou","year":"2021","journal-title":"Nano Today"},{"issue":"7","key":"10.1016\/j.biomaterials.2024.123063_bib22","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1021\/acs.nanolett.3c00434","article-title":"An intelligent cell-derived nanorobot bridges synergistic crosstalk between sonodynamic therapy and cuproptosis to promote cancer treatment","volume":"23","author":"Chen","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2024.123063_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102033","article-title":"Biological effects of metal-based nanomaterials for tumor metalloimmunotherapy","volume":"53","author":"Lei","year":"2023","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.123063_bib24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","article-title":"Systemic treatment of hepatocellular carcinoma: an EASL position paper","volume":"75","author":"Bruix","year":"2021","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.123063_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.123063_bib26","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3390\/cancers14102469","article-title":"Local and regional therapies for hepatocellular carcinoma and future combinations","volume":"14","author":"Hatzidakis","year":"2022","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.biomaterials.2024.123063_bib27","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1021\/jacs.1c02537","article-title":"Mild magnetic hyperthermia-activated innate immunity for liver cancer therapy","volume":"143","author":"Pan","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib28","article-title":"Engineered cancer cell membranes: an emerging agent for efficient cancer theranostics","volume":"2","author":"Guo","year":"2022","journal-title":"Explorations"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.123063_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.19.01307","article-title":"Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial","volume":"38","author":"Finn","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.123063_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202215467","article-title":"Oxygen-deficient molybdenum oxide nanosensitizers for ultrasound-enhanced cancer metalloimmunotherapy","volume":"62","author":"Wang","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.123063_bib32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"6506","key":"10.1016\/j.biomaterials.2024.123063_bib34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.biomaterials.2024.123063_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202205409","article-title":"Manganese-based tumor immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.123063_bib36","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide\u2013manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.123063_bib37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.123063_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.31635\/ccschem.021.202101458","article-title":"Sonosensitized aggregation-induced emission dots with capacities of immunogenic cell death induction and multivalent blocking of programmed cell death-ligand 1 for amplified antitumor immunotherapy","volume":"4","author":"Jia","year":"2021","journal-title":"CCS Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.123063_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204365","article-title":"Emerging sonodynamic therapy-based nanomedicines for cancer immunotherapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.123063_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12935-022-02585-z","article-title":"Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction","volume":"22","author":"Mardi","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.123063_bib41","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.accounts.0c00254","article-title":"Smart nanosized drug delivery systems inducing immunogenic cell death for combination with cancer immunotherapy","volume":"53","author":"Zhou","year":"2020","journal-title":"Acc. Chem. Res."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224005994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224005994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:08:10Z","timestamp":1777486090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224005994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":41,"alternative-id":["S0142961224005994"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.123063","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioactive microspheres to enhance sonodynamic-embolization-metalloimmune therapy for orthotopic liver cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.123063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123063"}}